إعلان مُمول
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
نشر بتاريخ
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
البحث
الأقسام
- National
- International
- Business
- Technology
- Health
- التعليم
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
إقرأ المزيد
Drama! Johnson slams Hazlewood for playing in IPL over national duty: 'We've ...'
Mitchell Johnson has criticised Josh Hazlewood's choice to play in the IPL instead of preparing...
IND vs ENG | Like England have Bashir, India should back Kuldeep: Ex-India cricketer
With Ashwin's retirement, Kuldeep Yadav is expected to lead India's spin attack in the upcoming...
Torii's Head Chef shares SRK-AbRam’s favorite dish
Torii, Gauri Khan's Mumbai restaurant, is a celebrity hotspot with a secret entrance for the Khan...
Madhyabindu Provincial Hospital upgraded to 100-bed facility
NAWALPARASI: Madhyabindu Provincial Hospital, located in Kawasoti-16, Danda of Nawalparasi...